Therapy insight: Venous-catheter-related thrombosis in cancer patients

Nature Clinical Practice Oncology

Volumn 3, Issue 4, 2006, Pages 214-222

  Agnelli, Giancarlo ^a   Verso, Melina ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b University Hospital   (Italy)

Author keywords

Central venous catheter; Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; D DIMER; DALTEPARIN; DNA FRAGMENT; ENOXAPARIN; HEPARIN; PROTHROMBIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

AUTOPSY; BIOCOMPATIBILITY; BLOOD CLOT LYSIS; BLOOD VESSEL INJURY; BONE MARROW TRANSPLANTATION; CANCER; CANCER PATIENT; CANNULATION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CLINICAL FEATURE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DEVICE INFECTION; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; GENE MUTATION; HETEROZYGOSITY; HIGH RISK PATIENT; HUMAN; INCIDENCE; INDWELLING CATHETER; INFECTION RISK; INTERMETHOD COMPARISON; LONG TERM CARE; LOW DRUG DOSE; MEDLINE; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PHLEBOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; THROMBECTOMY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; VENOUS THROMBOEMBOLISM;

CATHETERIZATION, CENTRAL VENOUS; HUMANS; NEOPLASMS; VENOUS THROMBOSIS;

EID: 33645718977     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0458     Document Type: Review

References (98)

1. Broviac JW et al. (1973) A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 36: 602-605
2. Hickman RO et al. (1979) A modified right atrial catheter for access to the venous system in marrow transplant recipient. Surg Gynecol Obstet 148: 871-875
3. Niederhuber JE et al. (1982) Totally implanted venous and arterial access system to replace external catheter in cancer treatment. Surgery 92: 706-712
4. Bregenzer T et al. (1998) Is routine replacement of peripheral intravenous catheters necessary? Arch Intern Med 158: 151-156
5. Lam S et al. (1994) Peripherally inserted central catheters in an acute-care hospital. Arch Intern Med 154: 1833-1837
6. Mansfield PF et al. (1994) Complication and failure of subclavian-vein catheterization. N Engl J Med 331: 1735-1738
7. Hoch JR (1997) Management of the complications of long-term venous access. Semin Vasc Surg 10: 135-143
8. Xiang DZ et al. (1998) Composition and formation of the sleeve enveloping a central venous catheter. J Vasc Surg Aug 28: 260-271
9. Raad II et al. (1994) The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 271: 1014-1016
10. Burt ME et al. (1981) Prospective evaluation of subclavian vein thrombosis during total parenteral nutrition by contrast venography. Clin Res 29: 264-267
11. Brismar B et al. (1982) Reduction of catheter-associated thrombosis in parenteral nutrition by intravenous heparin therapy. Arch Surg 117: 1196-1199
12. Pottecher T et al. (1984) Thrombogenicity of central venous catheters: prospective study of polyethylene, silicone and polyurethane catheters with phlebography or post-mortem examination. Eur J Anaesthesiol 1: 361-365
13. Bern HM et al. (1990) Very low dose of warfarin can prevent thrombosis in central venous catheters: A randomized, prospective trial. Ann Intern Med 112: 423-428
14. Balestrieri L et al. (1995) Central venous catheter-related thrombosis in clinically asymptomatic oncologic patients: A phlebographic study. Eur J Radiol 20: 108-111
15. Monreal M et al. (1996) Upper extremity deep venous thrombosis in cancer patients with venous access devices. Prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 75: 251-253
16. De Cicco M et al. (1997) Central venous thrombosis: An early and frequent complication in cancer patients bearing long term silastic catheter: A prospective study. Thromb Res 86: 101-113
17. Frank DA et al. (2000) The treatment and outcome of cancer patients with thromboses on central venous catheters. J Thromb Thrombolysis 10: 271-275
18. Verso M et al. (2005) Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: A double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 23: 4057-4062
19. Cortellezzi A et al. (2005) Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study. Br J Haem 129: 811-817
20. Martin C et al. (1999) Upper extremity deep vein thrombosis after central venous catheterization via the axillary vein. Crit Care Med 27: 2626-2629
21. Trerotola SO et al. (2000) Tunneled infusion catheters: Increased incidence of symptomatic venous thrombosis after subclavian versus internal jugular venous access. Radiology 217: 89-93
22. Duerksen DR et al. (1999) Peripherally inserted central catheters for parenteral nutrition: A comparison with centrally inserted catheters. JPEN J Parenter Enteral Nutr 23: 85-89
23. Cowl CT et al. (2000) Complications and cost associated with parenteral nutrition delivered to hospitalized patients through either subclavian or peripherally inserted central catheters. Clin Nutr 19: 237-243
24. Lersch C et al. (1999) Initial experience with Healthport miniMax and other peripheral arm port in patients with advanced gastrointestinal malignancy. Oncology 57: 269-275
25. Gould JR et al. (1999) Groshong catheter-associated subclavian venous thrombosis. Am J Med 95: 419-423
26. Pierce CM et al. (2000) Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Med 26: 967-972
27. Biffi R et al. (2001) A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 92: 1204-1212
28. Luciani A et al. (2001) Catheter-related upper extremity deep venous thrombosis in cancer patients: A prospective study based on doppler US. Radiology 220: 655-660
29. Mueller BU et al. (1992) A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus subcutaneously implanted device in cancer patients. J Clin Oncol 10: 1943-1948
30. Borow M and Crowley JG (1985) Evaluation of central venous catheter thrombogenicity. Acta Anest Scand Suppl 81: S59-S64
31. Eastridge BJ and Lefor AT (1995) Complications of indwelling venous access devices in cancer patients. J Clin Oncol 13: 233-238
32. Grove JR and Pevec WC (2000) Venous thrombosis related to peripherally inserted central catheters. J Vasc Interv Radiol 11: 837-840
33. Petersen J et al. (2000) Silicone venous access devices positioned with their tip high in the superior vena cava are more likely to malfunction. Am J Surg 178: 78-79
34. Puel V et al. (1993) Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. Cancer 72: 2248-2252
35. McBride KD et al. (1997) A comparative analysis of radiological and surgical placement of central venous catheters. Cardiovasc Intervent Radiol 20: 17-22
36. Verso M et al. (2005) Risk factors for CVC-associated thrombosis in cancer patients: Analysis of ETHIC study [abstract #P2188]. J Thromb Haemost 3 (Suppl 1)
37. McGee WT et al. (1993) Accurate placement of central venous catheters: A prospective, randomized, multicenter trial. Crit Care Med 21: 1118-1123
38. Lameris JS et al. (1990) Percutaneous placement of Hickman catheters: comparison of sonographically guided and blind techniques. Am J Roentgenol 155: 1097-1099
39. Lorenz JM et al. (2001) Radiologic placement of implantable chest ports in pediatric patients. Am J Roentgenol 176: 991-994
40. Denys BG et al. (1993) Ultrasound-assisted cannulation of the internal jugular vein: A prospective comparison to the external landmark-guided technique. Circulation 87: 1557-1562
41. Kraybill WG and Allen BT (1993) Preoperative duplex venous imaging in the assessment of patients with venous access. J Surg Oncol 5: 244-248
42. Timsit JF et al. (1998) Central vein catheter-related thrombosis in intensive care patients: Incidence, risk factors and relationship with catheter-related sepsis. Chest 114: 207-213
43. Van Rooden CJ et al. (2005) Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: A prospective study. J Clin Oncol 23: 2655-2660
44. Francis CW et al. (1997) Thrombin activity associated with indwelling central venous catheters. Thromb Haemost 77: 48-52
45. Koksoy C et al. (1995) The risk factors in central venous catheter-related thrombosis. Aust N Z J Surg 65: 796-798
46. De Cicco M et al. (1995) Antithrombin III deficiency as a risk factor for catheter-related central vein thrombosis in cancer patients. Thromb Res 78: 127-137
47. Riordan M and Weiden PL (1998) Factor V Leiden mutation does not account for central venous catheter-related thrombosis. Am J Hematol 58: 150-152
48. Wermes C et al. (1999) Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters. Eur J Pediatr 158 (Suppl 3): S143-S146
49. Fijnheer R et al. (2002) Factor V Leiden in central venous catheter-associated thrombosis. Br J Haematol 118: 267-270
50. Van Rooden CJ et al. (2004) The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis. Haematologica 89: 201-206
51. Jansen FH et al. (2005) Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis. Haematologica 90: 499-504
52. Brown DF et al. (1997) Mode of chemotherapy does not affect complications with an implantable venous access device. Cancer 80: 966-972
53. Koksoy C et al. (1995) The diagnostic value of colour Doppler ultrasound in central venous catheter related thrombosis. Clin Radiol 50: 687-689
54. Shankar KR et al. (2002) Magnetic resonance venography in assessing venous patency after multiple venous catheters. J Pediatr Surg 37: 175-179
55. Forneris G et al. (2001) Spiral x-ray computed tomography in the diagnosis of central venous catheterization complications [French]. Nephrologie 22: 495-499
56. Randolph AG et al. (1998) Benefit of heparin in central venous and pulmonary artery catheters: A meta-analysis of randomized controlled trials. Chest 113: 165-171
57. Karthaus M et al. (2005) Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: Final results of a double-blind, placebo-controlled phase III trial. Ann Oncol 17: 289-296
58. Couban S et al. (2005) Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 23: 4063-4069
59. Buller HR et al. (2004) Antithrombotic therapy for venous thromboembolic disease. Chest 126 (Suppl): S401-S428
60. Meyer G et al. (2002) Comparison of low-molecular-weight-heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: A randomized controlled study. Arch Intern Med 162: 1729-1735
61. Lee YYA et al. (2003) Low molecular weight heparin versus a coumarin for the prevention of the recurrent venous thromboembolism in patients with cancer. N Engl J Med 349: 146-153
62. Savage KJ et al. (1999) Outpatient use of low molecular weight heparin (dalteparin) for the treatment of deep vein thrombosis of the upper extremity. Thromb Haemost 82: 1008-1010
63. Spence LD et al. (1999) Acute upper extremity deep venous thrombosis: safety and effectiveness of superior vena caval filters. Radiology 210: 53-58
64. Ascher E et al. (2000) Lesson learned from a 6-year clinical experience with superior vena cava Greenfield filters. J Vasc Surg 32: 881-887
65. Blackett RL et al. (1978) A prospective study of subclavian vein catheters used exclusively for the purpose of intravenous feeding. Br J Surg 193: 264-270
66. Di Costanzo J et al. (1980) Venous thrombosis due to central venous catheters during total parenteral nutrition. JPEN J Parenter Enteral Nutr 4: 439-441
67. Lokich JJ and Becker B (1983) Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy. Cancer 52: 1586-1589
68. Wagman LD et al. (1984) Venous access: A prospective, randomized study of the Hickman catheter. Surgery 95: 303-308
69. Raaf JH (1985) Results from use of 826 vascular access devices in cancer patients. Cancer 55: 1312-1321
70. Cassidy FP Jr et al. (1987) Noninfectious complications of long-term central venous catheters: Radiologic evaluation and management. Am J Roentgenol 149: 671-675
71. Moss JF et al. (1989) Central venous thrombosis related to the silastic Hickman-Broviac catheter in an oncologic population. JPEN J Parenter Enteral Nutr 13: 397-400
72. Wenke K and Markewitz A (1990) Fully implantable catheter systems: long-term results-complications. Fortschr Med 108: 276-279
73. Jansen RF et al. (1990) Assessment of insertion techniques and complication rates of dual lumen central venous catheters in patients with hematological malignancies. World J Surg 14: 100-104
74. Haire WD et al. (1990) Hickman catheter-induced thoracic vein thrombosis: Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation. Cancer 66: 900-908
75. Metz RI et al. (1990) Percutaneous catheterization of the axillary vein in infants and children. Pediatrics 85: 531-533
76. Rau WS et al. (1991) The implantation of Hickman catheters: A new function of interventional radiology [German]. Radiologe 31: 125-131
77. Gould JR et al. (1993) Groshong catheter-associated subclavian venous thrombosis. Am J Med 95: 419-423
78. Torromade JR et al. (1993) The complications of central venous access system: A study of 218 patients. Eur J Surg 159: 323-332
79. Wesenberg F et al. (1993) Central venous catheter with subcutaneous injection port (port a cath): 8 years clinical follow up with children. Pediatr Hematol Oncol 10: 233-239
80. Soh LT and Ang PT (1993) Implantable subcutaneous infusion ports. Support Care Cancer 1: 108-110
81. Anderson AJ et al. (1995) Thrombosis: The major Hickman catheter complication in patients with solid tumor. Chest 95: 71-75
82. Horne MK III et al. (1995) Venographic surveillance of tunneled venous access devices in adult oncology patients. Ann Surg Oncol 2: 174-178
83. Cunningham MJ et al. (1996) Peripheral infusion ports for central venous access in patients with gynecologic malignancies. Gynecol Oncol 60: 397-399
84. Dubois J et al. (1997) Peripherally inserted central catheters in infants and children. Radiology 204: 622-626
85. Nightingale CE et al. (1997) A prospective analysis of 949 long-term central venous catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy. Eur J Cancer 33: 398-403
86. Wilimas JA et al. (1998) Late vascular occlusion of central lines in pediatric malignancies. Pediatrics 101: E7
87. Knofler R et al. (1999) Clinical importance of prothrombotic risk factors in pediatric patients with malignancy-impact of central venous lines. Eur J Pediatr 158 (Suppl 3): S147-S150
88. Schwarz RE et al. (2000) Transcutaneously tunneled central venous lines in cancer patients: An analysis of device-related morbidity factors based on prospective data collection. Ann Surg Oncol 7: 441-449
89. Lagro SW et al. (2000) No effect of nadroparin prophylaxis in the prevention of central catheter (CVC)-associated thrombosis in bone marrow transplant recipients. Bone Marrow Transplant 26: 1103-1106
90. Hartkamp A et al. (2000) Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems. Neth J Med 57: 215-223
91. Povoski SP (2000) A prospective analysis of the cephalic vein cutdown approach for chronic indwelling central venous access in 10 consecutive cancer patients. Ann Surg Oncol 7: 496-502
92. Coccaro M et al. (2001) Long-term infusional systems: Complications in cancer patients. Tumori 87: 308-311
93. Harter C et al. (2002) Catheter-related infection and thrombosis of the internal jugular vein in hematologic-oncologic patients undergoing chemotherapy: A prospective comparison of silver coated and uncoated catheters. Cancer 94: 245-251
94. Kuriakose P et al. (2002) Risk of deep venous thrombosis associated with chest versus arm central venous subcutaneous port catheters: A 5-year single-institution retrospective study. J Vasc Interv Radiol 13: 179-184
95. Stoney WS et al. (1976) The incidence of venous thrombosis following long-term transvenous pacing. Ann Thorac Surg 22: 166-170
96. Valerio D et al. (1981) Central vein thrombosis associated with intravenous feeding - a prospective study. JPEN J Parenter Enteral Nutr 5: 240-242
97. Bozetti F et al. (1983) Subclavian vein thrombosis due to indwelling catheters: A prospective study on 52 patients. JPEN J Parenter Enteral Nutr 7: 560-562
98. Glaser DW et al. (2001) Catheter-related thrombosis in children with cancer. J Pediatr 138: 255-259